These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23348905)

  • 1. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma.
    Krings G; Ramachandran R; Jain D; Wu TT; Yeh MM; Torbenson M; Kakar S
    Mod Pathol; 2013 Jun; 26(6):782-91. PubMed ID: 23348905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA; Ahmed NS
    Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
    Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
    Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
    Timek DT; Shi J; Liu H; Lin F
    Am J Clin Pathol; 2012 Aug; 138(2):203-10. PubMed ID: 22904131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: A clinicopathological and immunohistochemical study of 116 cases from a tertiary care hospital in Southern India.
    Hui M; Uppin SG; Uppin MS; Madhav TV; Varma GSR; Paul TR; Bheerappa N
    Indian J Cancer; 2023; 60(2):191-198. PubMed ID: 37530240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
    Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R
    Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.
    Clark I; Shah SS; Moreira R; Graham RP; Wu TT; Torbenson MS; Chandan V
    Hum Pathol; 2017 Nov; 69():90-95. PubMed ID: 28970136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
    Chandan VS; Shah SS; Torbenson MS; Wu TT
    Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
    Giedl J; Büttner-Herold M; Wach S; Wullich B; Hartmann A; Agaimy A
    Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
    Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
    Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma.
    Fatima N; Cohen C; Siddiqui MT
    Acta Cytol; 2014; 58(1):83-8. PubMed ID: 24281232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
    Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
    Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific characteristics of scirrhous hepatocellular carcinoma.
    Sugiki T; Yamamoto M; Taka K; Nakano M
    Hepatogastroenterology; 2009; 56(93):1086-9. PubMed ID: 19760947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alanine-glyoxylate aminotransferase 1 (AGXT1) is a novel marker for hepatocellular carcinomas.
    Zhao CL; Hui Y; Wang LJ; Yang D; Yakirevich E; Mangray S; Huang CK; Lu S
    Hum Pathol; 2018 Oct; 80():76-81. PubMed ID: 29883780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
    Atta IS
    Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
    Yan BC; Gong C; Song J; Krausz T; Tretiakova M; Hyjek E; Al-Ahmadie H; Alves V; Xiao SY; Anders RA; Hart JA
    Am J Surg Pathol; 2010 Aug; 34(8):1147-54. PubMed ID: 20661013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M; Kwok S; Yano H; Pai RK
    Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
    McKnight R; Nassar A; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.
    Lagana SM; Salomao M; Remotti HE; Knisely AS; Moreira RK
    Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.